|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.92 SEK | -1.16% |
|
-5.14% | +4.60% |
| Capitalization | 3.4B 368M 317M 295M 275M 511M 33.26B 549M 1.34B 15.9B 1.38B 1.35B 58.33B | P/E ratio 2025 * |
-6.54x | P/E ratio 2026 * | -7.37x |
|---|---|---|---|---|---|
| Enterprise value | 2.45B 265M 228M 213M 198M 368M 23.96B 395M 962M 11.45B 994M 974M 42.02B | EV / Sales 2025 * |
874x | EV / Sales 2026 * | 1,221x |
| Free-Float |
80.91% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Vicore Pharma Holding AB
More recommendations
More press releases
| 1 day | -1.16% | ||
| 1 week | -5.14% | ||
| Current month | +4.60% | ||
| 1 month | +18.20% | ||
| 3 months | +1.90% | ||
| 6 months | +49.81% | ||
| Current year | +4.60% |
| 1 week | 11.6 |  | 12.88 |
| 1 month | 9.32 | | 13.06 |
| Current year | 10.5 | | 13.06 |
| 1 year | 6.09 | | 14.1 |
| 3 years | 6.09 | | 26.9 |
| 5 years | 6.09 | | 37.45 |
| 10 years | 5.7 | | 40 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ahmed Mousa
CEO | Chief Executive Officer | 42 | 08/09/2023 |
Hans Jeppsson
DFI | Director of Finance/CFO | - | 31/12/2016 |
Bertil Lindmark
CTO | Chief Tech/Sci/R&D Officer | 70 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 06/05/2024 | |
| Chairman | 59 | 22/03/2022 | |
Heidi Hunter
BRD | Director/Board Member | 67 | 31/12/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | -5.14% | +29.18% | -46.15% | 368M | |
| -0.95% | -0.37% | +7.80% | +88.39% | 49.52B | |
| +0.71% | +6.24% | +95.76% | +14.62% | 44.32B | |
| +1.26% | -7.91% | +122.76% | +747.57% | 33.97B | |
| +3.09% | +9.84% | -2.74% | -23.41% | 26.62B | |
| +0.97% | +0.18% | +43.30% | -21.70% | 20.71B | |
| -0.60% | +9.17% | +128.36% | -45.21% | 21.22B | |
| -0.74% | -5.62% | +114.16% | +148.46% | 14.4B | |
| +0.72% | +0.98% | +192.83% | - | 14.07B | |
| +0.64% | -11.79% | -4.56% | +278.21% | 13.32B | |
| Average | +0.37% | +0.06% | +72.68% | +126.75% | 23.85B | |
| Weighted average by Cap. | +0.51% | +1.13% | +69.83% | +152.44% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.8M 304K 261K 244K 227K 422K 27.43M 452K 1.1M 13.11M 1.14M 1.12M 48.1M | 2.33M 253K 218K 203K 189K 351K 22.86M 377K 918K 10.93M 949K 929K 40.09M |
| Net income | -443M -48.01M -41.35M -38.54M -35.85M -66.7M -4.34B -71.55M -174M -2.07B -180M -176M -7.61B | -439M -47.6M -41M -38.21M -35.55M -66.13M -4.3B -70.94M -173M -2.06B -178M -175M -7.54B |
| Net Debt | -949M -103M -88.66M -82.62M -76.87M -143M -9.3B -153M -374M -4.45B -386M -378M -16.31B | -546M -59.15M -50.95M -47.48M -44.17M -82.18M -5.34B -88.15M -215M -2.55B -222M -217M -9.37B |
More financial data
* Estimated data
Employees
36
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 11.82 kr | -1.99% | 613,581 |
| 15/01/26 | 12.06 kr | -1.79% | 684,604 |
| 14/01/26 | 12.28 kr | +0.49% | 708,059 |
| 13/01/26 | 12.22 kr | +0.66% | 689,177 |
| 12/01/26 | 12.14 kr | -2.57% | 961,189 |
Delayed Quote Nasdaq Stockholm, January 16, 2026 at 03:08 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
12.06SEK
Average target price
32.40SEK
Spread / Average Target
+168.66%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VICO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition